Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients
Status: ENROLLING_BY_INVITATION
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Peripheral Neuropathy|Cardiac Toxicities|Hepatic Toxicity|Cognitive Impairment
Interventions: DRUG: Silymarin|DRUG: Placebo
Sponsor: Tanta University